Literature DB >> 29474575

TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity.

Christine Leibiger1, Jana Deisel1, Andreas Aufschnaiter2, Stefanie Ambros1, Maria Tereshchenko1, Bert M Verheijen3,4, Sabrina Büttner2,5, Ralf J Braun1.   

Abstract

TDP-43 is a nuclear RNA-binding protein whose cytoplasmic accumulation is the pathological hallmark of amyotrophic lateral sclerosis (ALS). For a better understanding of this devastating disorder at the molecular level, it is important to identify cellular pathways involved in the clearance of detrimental TDP-43. Using a yeast model system, we systematically analyzed to which extent TDP-43-triggered cytotoxicity is modulated by conserved lysosomal clearance pathways. We observed that the lysosomal fusion machinery and the endolysosomal pathway, which are crucial for proper lysosomal function, were pivotal for survival of cells exposed to TDP-43. Interestingly, TDP-43 itself interfered with these critical TDP-43 clearance pathways. In contrast, autophagy played a complex role in this process. It contributed to the degradation of TDP-43 in the absence of endolysosomal pathway activity, but its induction also enhanced cell death. Thus, TDP-43 interfered with lysosomal function and its own degradation via lysosomal pathways, and triggered lethal autophagy. We propose that these effects critically contribute to cellular dysfunction in TDP-43 proteinopathies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29474575     DOI: 10.1093/hmg/ddy066

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.

Authors:  Guangbo Liu; Aaron Byrd; Amanda N Warner; Fen Pei; Eman Basha; Allison Buchanan; J Ross Buchan
Journal:  Mol Cell Biol       Date:  2020-01-30       Impact factor: 4.272

Review 2.  Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Authors:  Han-Jou Chen; Jacqueline C Mitchell
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

3.  Diallyl Trisulfide Protects Motor Neurons from the Neurotoxic Protein TDP-43 via Activating Lysosomal Degradation and the Antioxidant Response.

Authors:  Chang Liu; Bingquan Leng; Yi Li; Hong Jiang; Weisong Duan; Yansu Guo; Chunyan Li; Kun Hong
Journal:  Neurochem Res       Date:  2018-10-13       Impact factor: 3.996

Review 4.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

5.  Respiration Enhances TDP-43 Toxicity, but TDP-43 Retains Some Toxicity in the Absence of Respiration.

Authors:  Sei-Kyoung Park; Sangeun Park; Susan W Liebman
Journal:  J Mol Biol       Date:  2019-03-21       Impact factor: 5.469

Review 6.  Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.

Authors:  Lindsey R Hayes; Petr Kalab
Journal:  Neurotherapeutics       Date:  2022-07-05       Impact factor: 6.088

Review 7.  The emerging mechanisms and functions of microautophagy.

Authors:  Liming Wang; Daniel J Klionsky; Han-Ming Shen
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-12       Impact factor: 113.915

Review 8.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jessica Root; Paola Merino; Austin Nuckols; Michelle Johnson; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2021-03-31       Impact factor: 7.046

Review 9.  ALS Yeast Models-Past Success Stories and New Opportunities.

Authors:  Sonja E Di Gregorio; Martin L Duennwald
Journal:  Front Mol Neurosci       Date:  2018-10-30       Impact factor: 5.639

10.  Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam.

Authors:  Bert M Verheijen; Kiyomitsu Oyanagi; Fred W van Leeuwen
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.